SRN-901: The Longevity Drug That Beat Rapamycin in Mice
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
A new compound called SRN-901 just extended mouse lifespan by 33%. And it did it head-to-head against the three most-hyped longevity interventions on the market: rapamycin, NMN, and NR. SRN-901 outperformed all of them.
Paper: Weiss EP, Skoog VA, Klaus C, et al. (2026). SRN-901, a novel longevity drug, extends lifespan and healthspan in aging mice better than other anti-aging treatments. Drug Design, Development and Therapy 20, 1419-1438.
DOI: https://doi.org/10.2147/DDDT.S594895
AI x biology · 5 min · Source published: 2026-05-29
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.